Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1762 (LINC01762) is a non-protein-coding RNA gene annotated in human genome databases, defined by its position between but not overlapping protein-coding genes and its transcript of longer than 200 nucleotides. As with other lincRNAs, its putative roles may include chromatin remodeling and fine-tuning transcriptional activity, but no experimental data are available regarding its specific function, disease involvement, or clinical relevance[1][3][5][7]. It is cataloged under accession numbers 101929023 (NCBI Gene) and ENSG00000233154 (Ensembl)[1].
None described for LINC01762. Mechanisms typically assigned to drug-lincRNA interactions (such as antisense inhibition or expression modulation) do not have supporting evidence here.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1762 (LINC01762).